Arrhythmogenic Right Ventricular Dysplasia Market to Grow at 4.3% CAGR by 2031, Driven by U.S. & Japan Innovations and Genotype-Phenotype Breakthroughs

The Global Arrhythmogenic Right Ventricular Dysplasia Market is expected to reach US$ 1.2 billion by 2031 growing with a CAGR of 4.3% during the forecast period 2024-2031. The arrhythmogenic right ventricular dysplasia market is driven by factors such as genetic research, technological advancements, and personalized medicine.

Arrhythmogenic Right Ventricular Dysplasia Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/arrhythmogenic-right-ventricular-dysplasia-market?un

Industry News of USA and Japan:

USA

• Tenaya Therapeutics received positive safety recommendations from independent DSMBs, allowing planned dose-escalation and expansion for TN-401 (PKP2-ARVC) and TN-201 programs (July 2025).

• Tenaya's Q2 2025 update highlighted steady enrollment progress in the RIDGE-1 study for TN-401, with additional clinical readouts expected later in 2025.

• Lexeo Therapeutics advanced its LX2020 (PKP2 gene therapy) program, reporting dosing and enrollment updates with an interim clinical update anticipated in H2 2025; LX2020 holds FDA orphan and fast-track designations.

• Multiple PKP2-targeted AAV gene therapy trials are actively enrolling, marking a strong wave of gene therapy innovation for ARVC in the U.S.

• Continued funding and financing updates from U.S. gene therapy developers provide runway support for ARVC clinical programs through 2025.

Japan

• Japanese researchers and clinicians actively presented new findings on arrhythmia and cardiomyopathy at APHRS/JHRS 2025 meetings, including sessions focused on genetic ARVC.

• Recent Japanese studies continue to highlight genotype-phenotype links, especially DSG2 and other desmosomal mutations, in local ARVC populations.

• Updated guidance from Japanese cardiac societies emphasizes adoption of wearable and remote ECG monitoring technologies, supporting earlier detection and management of ARVC.

Key Players:

• Centogene AG,

• Ambry Genetics,

• GeneDx.,

• Illumina Inc.,

• Asper Biogene.,

• Cohesion Phenomics,

• Blueprint Genetics Oy,

• Aetna Inc,

• Invitae Corporation,

• Medanta

Growth Forecast Projected:

The Global Arrhythmogenic Right Ventricular Dysplasia Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Arrhythmogenic Right Ventricular Dysplasia Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=arrhythmogenic-right-ventricular-dysplasia-market

Market Segmentation:

➤ By Surgical Treatment: Implantable Cardioverter Defibrillator (ICD), Ventricular Assist Device (VAD), Pacemaker, Septal Myectomy, Heart Transplant, Others

➤ By Non-Surgical Treatment: Septal Ablation, Radiofrequency Ablation Liver Transplantation, Drugs

➤ By End-user: Hospitals, Specialty Clinics, Diagnostics Imaging Center, Ambulatory Surgery Center, Academic and Research Institutes, Others

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/arrhythmogenic-right-ventricular-dysplasia-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Arrhythmogenic Right Ventricular Dysplasia Market?

➠ Who are the leading manufacturers in the global Parkinson's disease Therapeutics industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Parkinson's disease Therapeutics industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Arrhythmogenic Right Ventricular Dysplasia Market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.